Clinical Trials Directory

Trials / Unknown

UnknownNCT05640128

Determination of Threshold Values of Aldosterone in HPLC-MS/MS, of Renin and of the Aldosterone / Renin Ratio for the Diagnosis of Primary Hyperaldosteronism

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

collaborative work within 2 hospitals at the CHU of Caen, at the CHRU of Lille, concerning the evaluation of the biological markers of primary hyperaldosteronism (PAH) with the dosage of aldosterone in LC -MS/MS, which is performed in both centers, with two different techniques. The main objective is to define the range of Aldosterone concentrations in LC MS/MS, of renin in an automated method, in populations of healthy volunteers, essential hypertensives, and hypertensives with primary hyperaldosteronism. , in order to establish a threshold for the screening of PAH by the RAR, and for the confirmation of PAH by a dynamic test with an Aldosterone threshold post salt load test.

Conditions

Interventions

TypeNameDescription
OTHERAldosterone in HPLC-MS/MSAldosterone in HPLC-MS/MS

Timeline

Start date
2018-01-02
Primary completion
2023-01-02
Completion
2024-01-01
First posted
2022-12-07
Last updated
2022-12-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05640128. Inclusion in this directory is not an endorsement.